![Michael Bigham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bigham
Directeur/Membre du Conseil chez
TeneoBio, Inc.
Profil
Fondateur de Magellan Diagnostics, Inc, Michael F. Bigham est un homme d'affaires qui a été à la tête de 6 entreprises différentes et qui est actuellement président exécutif de Paratek Pharmaceuticals, Inc. Il est également membre du conseil d'administration d'Adamas Pharmaceuticals, Inc. et d'Inmediata Health Group (ancien président), d'inMediata Corp. et de Frazier Lifesciences Acquisition Corp. Dans le passé, il a occupé les postes de directeur financier et de vice-président exécutif des opérations chez Gilead Sciences, Inc. et d'associé exécutif chez Abingworth Management Ltd. et d'associé chez Abingworth LLP (une filiale d'Abingworth Management Ltd.), ainsi que de président et de directeur général de Paratek Pharmaceuticals, Inc, Président du conseil d'administration de Magellan Diagnostics, Inc. et directeur d'Avila Therapeutics, Inc. et président-directeur général de Coulter Pharmaceuticals, Inc. et associé et co-responsable des services bancaires d'investissement dans le domaine de la santé chez Hambrecht & Quist Group, Inc. Il a obtenu un diplôme de premier cycle à l'université de Virginie et un MBA à l'université de Stanford.
Postes actifs de Michael Bigham
| Sociétés | Poste | Début |
|---|---|---|
TeneoBio, Inc.
 TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Directeur/Membre du Conseil | - |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Bigham
| Sociétés | Poste | Fin |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Directeur Général | 25/06/2019 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 24/11/2021 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01/11/2015 |
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/12/2013 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Directeur Général | 01/01/2012 |
Formation de Michael Bigham
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Operates as a holding investment bank and provides securities brokerage services | Finance |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Operates as an investment firm | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Inmediata Health Group
 Inmediata Health Group Electronic Production EquipmentElectronic Technology Offers electronic solutions for enhancing the efficiency and the quality of health and dental care | Electronic Technology |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
inMediata Corp.
 inMediata Corp. Regional BanksFinance Provides payment reconciliation solutions | Finance |
TeneoBio, Inc.
TeneoBio, Inc. Pharmaceuticals: MajorHealth Technology Develops human heavy chain antibodies for therapeutics against cancer | Health Technology |
Magellan Biosciences, Inc.
 Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory | Health Technology |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
